Navigation Links
Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
Date:5/8/2012

n driven by lower demand of certain products and pricing pressures on a key product. This decrease was partially offset by new product sales of $1 million. Reported operating margin increased 190 basis points to 29.4%, while adjusted operating margin increased 210 basis points to 30.8%.  

For the first nine months of fiscal 2012, net sales increased 7% or $8 million to $127 million, compared to $119 million in fiscal 2011. This increase was due to new product sales of $6 million, increased sales of existing products of $1 million, and favorable changes in foreign currency exchange rates of $1 million.

On March 21, 2012, the Company announced that it received a final "Approval for Registration" letter from the Australian Therapeutic Goods Administration permitting the Company to sell generic temozolomide in Australia.

Other

Continuing operations for the Other category, consisting of the Israel Pharmaceutical and Diagnostic Products operating segment, reported third quarter net sales of $19 million, an increase of 12% compared to fiscal 2011. This increase was due to new product sales of $1 million, along with an increase in sales of existing products of $1 million. For the first nine months of fiscal year 2012, net sales were $56 million, an increase of 15% compared to fiscal 2011, driven by new product sales of $4 million and an increase in sales of existing products of approximately $4 million.

Guidance

Reported fiscal 2012 earnings from continuing operations are expected to be between $4.10 and $4.20 per diluted share. Excluding the charges outlined in Table III at the end of this release, expected fiscal 2012 adjusted earnings from continuing operations are expected to be between $4.90 and $5.00 per diluted share, up from previously announced guidance of $4.70 to $4.80 per diluted share, due to the inclusion of the $0.20 per diluted share tax benefit realized in the fiscal third quarter. This new range implies a yea
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... 2015 La sofisticada aplicación ... sistemas de imagen por Ultrasonidos   ofrece resultados más ... rápidos y un flujo de trabajo   optimizado, lo ... proceso de detección de Cardiopatías   ... el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
(Date:8/28/2015)... 28, 2015 According to a ... (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling ... Prognostic) & Geography - Global Forecast to 2020", published ... reach around 17,689.0 Million USD by 2020 at a ... to 2020. Browse 191 Tables and ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5
... , , STAMFORD, Conn., Jan. 8 ... (Nasdaq: SPDE ), today announced that Health Canada, ... the Zargis Cardioscan(TM) device for sale in Canada. , ... a Bluetooth®-enabled electronic stethoscope and is designed to help ...
... 8 Somanetics Corporation (Nasdaq: SMTS ) will release its ... 30, 2009 before the opening of the market on Thursday, January ... Company will host a conference call that will be webcast live ... On the conference call, Bruce Barrett, Somanetics, president and chief executive ...
Cached Medicine Technology:Zargis Cardioscan Cleared for Sale in Canada 2Zargis Cardioscan Cleared for Sale in Canada 3Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010 2
(Date:8/31/2015)... ... August 31, 2015 , ... According to book reviewer ... Charge of Your Life with Cancer is an excellent resource for everyone since ... Cancer Solution to be helpful in explaining what cancer is in a easy to ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... Awareness campaign, TAKE ACTION. NOT CHANCES. (SM) will be featured on a digital ... eye-catching campaign image is designed to inspire and promote earlier awareness of the ...
(Date:8/31/2015)... Florida (PRWEB) , ... August 31, 2015 , ... ... is excited to establish its first Digital Hub in North America, now open ... before selecting Florida,” stated Founder and CEO John Campbell. “Jacksonville’s lifestyle, waterways and ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... products for the water, food, health sciences and consumer goods industries, has recognized ... their advanced iron filtration media, Pro-OX Manganese Dioxide. , Developed by a team ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Adult & Pediatric ... Denver area dermatology patients of the treatments and services available to help them. ... utilizing an innovative and ‘responsive design’ that allows visitors to view the website seamlessly ...
Breaking Medicine News(10 mins):Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 3Health News:Global Digital Opens USA Digital Agency Hub 2Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 2Health News:NSF International Has Recognized Clean Water Systems & Stores Inc Facility 3Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 2Health News:Adult & Pediatric Dermatology Launches Responsive Design Website 3
... in more infants, study shows , TUESDAY, April 6 (HealthDay ... consistent advice from doctors, nurses and others are more likely ... recommended position for reducing the risk of SIDS. , U.S. ... 8 months to find out what advice the mothers had ...
... ... find the guaranteed lowest prices and free nationwide shipping. , ... Phoenix, AZ (PRWEB) April 6, 2010 -- ... the guaranteed lowest prices and free nationwide shipping., , , , ,LifeSpan fitness equipment ...
... cancer than ever before, young patients successfully treated in the ... than the general population, according to a study from Dana-Farber ... Depending on the type of cancer, the estimated loss of ... years, the scientists report in the April 6 issue of ...
... Swedish medical university Karolinska Institutet provides evidence that basic ... that also exist in the most primitive vertebrates, such ... an investigation into the limbic striatum, one of the ... to learn movements, consciously and unconsciously, through repetition. ...
... drug,s off-label use , TUESDAY, April 6 (HealthDay News) ... sclerosis (ALS), or Lou Gehrig,s disease, and shouldn,t be used ... findings from a new study contradict promising results from a ... off-label use of lithium to treat people with ALS, a ...
... ... software, because what people do online impacts their lives offline. , ... Owosso, MI (PRWEB) April 6, 2010 -- Providing ... one of the 2010 “Michigan 50 Companies to Watch.” , ,Covenant Eyes will ...
Cached Medicine News:Health News:It Takes a Village to Help Babies Sleep Safely 2Health News:LifeSpan Fitness Equipment Available at Fitness4HomeOnline.com 2Health News:LifeSpan Fitness Equipment Available at Fitness4HomeOnline.com 3Health News:Childhood cancer survivors may face shortened lifespan, study reveals 2Health News:Childhood cancer survivors may face shortened lifespan, study reveals 3Health News:Childhood cancer survivors may face shortened lifespan, study reveals 4Health News:Unconscious learning uses old parts of the brain 2Health News:No Evidence That Lithium Helps in ALS 2Health News:Covenant Eyes Honored as One of the 2010 “Michigan 50 Companies to Watch” 2Health News:Covenant Eyes Honored as One of the 2010 “Michigan 50 Companies to Watch” 3
... Pediatric Flowmeters, ,Options: , ... S to model number. Example: ... add suffix C to model ... Double Flowmeters with Power Take-Off, ...
FM Style Neonatal Flowmeters (Brass Body)...
... Adult Flowmeters, ,Options: , ... S to model number. Example: ... add suffix C to model ... Double Flowmeters with Power Take-Off, ...
... designed specifically for detection of recent-onset neovascular ... perimeter maps and quantifies visual field defects ... AMD to the wet stage of the ... compensate for small visual field defects, the ...
Medicine Products: